Research in Inflammation, Biomarkers, and Cardiovascular Risk
We study how inflammation drives cardiovascular, kidney, and metabolic diseases and translate our discoveries into tools for prevention, diagnosis, and patient care.
Inflammation & Cardiovascular-Kidney-Metabolic (CKM) Syndrome
Cardio-Oncology
From biomarker discovery to clinical insight, our research translates into measurable outcomes across publications, funding, mentorship, and multi-site collaboration.
The Team Behind the Science
Our multidisciplinary team of physicians, scientists, trainees, and research staff drives every aspect of our work — from bench discovery to clinical impact.
Salim Hayek, MD
Principal Investigator
Chair and Professor of Internal Medicine, UTMB
Physician-scientist focused on cardiovascular inflammation, biomarker discovery, cardio-oncology, and precision risk prediction.
Biomarkers | CKM Disease | Cardio-Oncology | Translational Research
